Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

Hemophagocytic lymphohistiocytosis (HLH), also defined as hemophagocytic syndrome (HPS), represents a potentially life-threatening hyperinflammatory syndrome, characterized by impaired function of cytotoxic T lymphocytes, natural killer cells and macrophages. The main clinical features of HLH are p...

Full description

Bibliographic Details
Main Author: Claudio Fozza
Format: Article
Language:English
Published: PAGEPress Publications 2024-01-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
acute myeloid leukemia
Hemophagocytic lymphohistiocytosis
Online Access:https://mjhid.org/mjhid/article/view/5564

Similar Items

Similar Items